Work

Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer’s Disease Patients: The CATIE-AD Study

Year: 2020

Type: article

Abstract: The second-generation antipsychotics are associated with metabolic abnormalities in patients with schizophrenia. Elderly patients with Alzheimer’s disease are frequently treated with these antipsychotics but there is little data available on their metabolic effects.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/dbd9-wm63

Authors: Dagerman, Karen S., Tariot, Pierre N., Sultzer, David L., Zheng, Ling, Vigen, Cheryl, Lyketsos, Constantine G., Lebowitz, Barry D., Stroup, T. Scott, Hsiao, John K., Schneider, Lon S., Mack, Wendy J.

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, University of Miami, University of Pennsylvania, Northwestern University, Wake Forest University, State University of New York, Johns Hopkins University, Louisiana State University, Dartmouth College, University of South Carolina, University of South Florida, Saint Louis University, University of North Carolina at Chapel Hill, University of California, San Diego, University of California, Irvine, National Institute of Mental Health

OpenAlex ID: W4300832005

FWCI: 0.183

Cites:

Cited by: 8

Related to: 10